Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...
Hims and Hers are being scrutinized after running a Super Bowl ad, claiming to be a less expensive alternative to Ozempic and ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Regularly evaluate and refine your approach based on performance data to improve your print advertising effectiveness. Newspaper commercials, while less prominent than before, can still be applicable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results